Saba Capital Sells 43,912 Shares in abrdn Life Sciences Investors

martes, 23 de septiembre de 2025, 1:57 pm ET1 min de lectura
HQL--

ABRDN Life Sciences Investors announces that Saba Capital Management, L.P., a 10% shareholder, has disposed of 6989 shares at a price of $14.1 each on September 19, 2025, and 41623 shares at a price of $14.14 each on September 22, 2025.

Saba Capital Sells 43,912 Shares in abrdn Life Sciences Investors

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios